Clinical Scorecard: Research Review: TFOS DEWS III Summary Pertaining to Contact Lenses
At a Glance
| Category | Detail |
|---|---|
| Condition | Dry Eye Disease (DED) |
| Key Mechanisms | Loss of tear film homeostasis, tear film instability, ocular surface inflammation, and neurosensory abnormalities. |
| Target Population | Contact lens wearers, particularly those with existing DED or at risk of developing DED. |
| Care Setting | Ophthalmology and optometry practices. |
Key Highlights
- DED is characterized by tear film instability and ocular surface damage.
- Contact lens discomfort symptoms overlap with DED symptoms.
- Contact lens wear can exacerbate existing DED or lead to its development.
- Management strategies include modifying lens materials and using nonpreserved lubricants.
- Contact lenses can also serve as treatment devices for tear film deficiencies.
Guideline-Based Recommendations
Diagnosis
- Use symptoms and signs to diagnose DED.
- Differentiate between contact lens discomfort and DED.
Management
- Follow TFOS DEWS III Management and Therapy report guidelines.
- Consider switching to daily disposable lenses and using nonpreserved lubricants.
Monitoring & Follow-up
- Assess ocular surface health and symptoms regularly in contact lens wearers.
Risks
- Contact lens wear is a consistent risk factor for developing DED.
Patient & Prescribing Data
Individuals wearing contact lenses, especially those with or at risk for DED.
Intense pulsed light (IPL) and thermal pulsation are beneficial for contact lens wearers with meibomian gland dysfunction.
Clinical Best Practices
- Utilize soft and scleral contact lenses for managing tear film deficiencies.
- Implement amniotic membranes under contact lenses for ocular surface abnormalities.
- Educate patients on the potential impact of contact lenses on ocular surface health.
References
- TFOS DEWS III: Executive Summary
- The TFOS International Workshop on Contact Lens Discomfort
- TFOS DEWS III: Digest
- TFOS Lifestyle: Impact of contact lenses on the ocular surface
- TFOS DEWS III: Management and Therapy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.